A Public Health Economic Assessment of Hospitals' Cost to Screen Newborns for Critical Congenital Heart Disease
Cora Peterson(National Center on Birth Defects and Developmental Disabilities), Cynthia H. Cassell(Centers for Disease Control and Prevention), Mary M. Knapp(New Jersey Department of Health), Leslie M. Beres(New Jersey Department of Health), Scott D. Grosse(National Center for Environmental Health), Jill Glidewell(Centers for Disease Control and Prevention), Lorraine F. Garg(New Jersey Department of Health), Cynthia F. Hinton(Centers for Disease Control and Prevention), Richard S. Olney(University of Iowa), Kim Van Naarden Braun(Centers for Disease Control and Prevention)
Cited by 47
Related Papers
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|582
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
|American Journal of Epidemiology|2000|535
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
|New England Journal of Medicine|2007|501
Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016
|MMWR Morbidity and Mortality Weekly Report|2017|299
Epidemiology of Biliary Atresia: A Population-based Study
|PEDIATRICS|1997|257